1-4 of 4
Deok Hwan Yang, M.D.
Close
Sort by
Journal Articles

Renal Adverse Effect of Anagrelide in Patients with Myeloproliferative Neoplasms

Yeo-Kyeoung Kim, M.D., Ph.D., Soo-Young Bae, MD, Li Yu, Ph.D., Nan-Young Kim, Ph.D., Se Ryeon Lee, M.D., Ph.D., Jae-Sook Ahn, M.D., Ph.D., Deok-Hwan Yang, M.D., Ph.D., Il-Kwon Lee, Ph.D., Je-Jung Lee, M.D., Ph.D., Hyeoung-Joon Kim, M.D., Ph.D.
Journal: Blood
Blood (2011) 118 (21): 5151.
https://doi.org/10.1182/blood.V118.21.5151.5151
Published: 2011
Journal Articles

The Impact of Alemtuzumab as a Component of Conditioning Regimens on Transplantation Outcomes in a Setting of CMV-Seropositive Recipient and Donor.

Byung Min Ahn, MD, Sang Kyun Sohn, M.D., Jong Kwang Kim, M.D., Yee Soo Chae, M.D., Yoon Young Cho, M.D., Joon Ho Moon, M.D., Deok Hwan Yang, M.D., Je-Jung Lee, M.D., Yeo-Kyeoung Kim, M.D., Hyeoung-Joon Kim, M.D.
Journal: Blood
Blood (2006) 108 (11): 5270.
https://doi.org/10.1182/blood.V108.11.5270.5270
Published: 2006
Journal Articles

The Presence of FLT3/ITD Mutations Is an Independent Prognostic Factor in Acute Myeloid Leukemia Patients with Normal Karyotype.

Yeo-Kyeoung Kim, M.D., Je-Jung Lee, M.D.&Ph.D., Yu-Ra Lee, Il-Kwon Lee, Ph.D., Hee-Nam Kim, Nan-Young Kim, Kyeong-Soo Park, M.D.&Ph.D., Deok-Hwan Yang, M.D., Moo-Rim Park, M.D.&Ph.D., Hyeoung-Joon Kim, M.D.&Ph.D.
Journal: Blood
Blood (2004) 104 (11): 3008.
https://doi.org/10.1182/blood.V104.11.3008.3008
Published: 2004
Journal Articles

Clinical Significance of FLT3 Internal Tandem Duplication in Patients with Acute Myeloid Leukemia Who Underwent Allogeneic Bone Marrow Transplantation.

Je-Jung Lee, M.D.&Ph.D., Yu-Ra Lee, Hee-Nam Kim, Nan-Young Kim, Kyeong-Soo Park, M.D.&Ph.D., Deok-Hwan Yang, M.D., Yeo-Kyeoung Kim, M.D., Hyeoung-Joon Kim, M.D. & Ph.D.
Journal: Blood
Blood (2004) 104 (11): 4419.
https://doi.org/10.1182/blood.V104.11.4419.4419
Published: 2004